As of May 11, QPS, a global contract research organization (CRO) that provides GLP-compliant discovery, preclinical, and clinical drug development services, has the capability to conduct COVID-19 testing.   QPS has developed and validated a quantitative polymerase chain reaction (QPCR) assay to identify active novel coronavirus infections (COVID-19). The assay is registered as a CLIA-certified assay in all US states requiring COVID-19 testing notifications. After an initial ramp-up, the laborato...